HLX-1502

· Healx Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX-1502, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 [Phase 2]

See pricing